David R. Staskin
Weill Medical College of Cornell University
New York
NY 10021
USA
Name/email consistency: high
- Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions. Staskin, D.R., Rosenberg, M.T., Dahl, N.V., Polishuk, P.V., Zinner, N.R. Int. J. Clin. Pract. (2008)
- Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial. Staskin, D., Sand, P., Zinner, N., Dmochowski, R. J. Urol. (2007)
- Using anticholinergics to treat overactive bladder: the issue of treatment tolerability. Staskin, D.R., MacDiarmid, S.A. Am. J. Med. (2006)
- Pharmacologic management of overactive bladder: practical options for the primary care physician. Staskin, D.R., MacDiarmid, S.A. Am. J. Med. (2006)
- Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence. Staskin, D.R., Te, A.E. BJU Int. (2006)
- Trospium chloride: Distinct among other anticholinergic agents available for the treatment of overactive bladder. Staskin, D.R. Urol. Clin. North Am. (2006)
- Overactive bladder in the elderly: a guide to pharmacological management. Staskin, D.R. Drugs. Aging (2005)
- The urge to define urgency: a review of three approaches. Staskin, D.R. Curr. Urol. Rep (2004)
- Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder. Staskin, D.R., Harnett, M.D. Curr. Urol. Rep (2004)
- Methodologic shortcomings inherent in a post-hoc analysis. Staskin, D.R. Curr. Urol. Rep (2002)
- Future studies of overactive bladder: the need for standardization. Staskin, D.R., Dmochowski, R.R. Urology (2002)